We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fresenius Hits Dr. Reddy's With Diprivan IP Suit

Law360, New York (May 24, 2013, 4:36 PM EDT) -- A subsidiary of Fresenius SE & Co. KGaA on Thursday accused the Indian pharmaceutical company Dr. Reddy’s Laboratories Ltd. and a U.S. unit of infringing four of its patents when Dr. Reddy’s applied to produce a generic version of the sedative Diprivan.

The suit, filed in Delaware federal court, claims Dr. Reddy’s has asked the U.S. Food and Drug Administration for approval of a generic version of the drug, despite having no reasonable basis to believe it wouldn’t be liable for infringing Fresenius’ patents.

The patents-in-suit...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.